Immuneering to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
February 27, 2023 08:00 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an...
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2022 After Market Close on February 27, 2023
February 21, 2023 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers,...
Blue Star Foods Closes $1.8 Million Underwritten Public Offering of Common Stock
February 14, 2023 09:45 ET
|
Blue Star Foods Corp.
MIAMI, FL, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (NASDAQ:BSFC) (the "Company" ), an integrated Environmental, Social, and Governance (ESG) sustainable seafood company with a focus...
Blue Star Foods Prices $1.8 Million Underwritten Public Offering of Common Stock
February 10, 2023 09:46 ET
|
Blue Star Foods Corp.
MIAMI, FL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (NASDAQ:BSFC) (the "Company" ), an integrated Environmental, Social, and Governance (ESG) sustainable seafood company with a focus...
Revolution Medicines to Participate in Upcoming Investor Conferences
February 02, 2023 07:00 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Qualigen Therapeutics Chief Executive Officer Michael Poirier Provides Letter to Stockholders
February 01, 2023 09:05 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for...
Blue Star Foods Corp. Engages ShareIntel to Combat Alleged Illegal Short Selling
February 01, 2023 08:30 ET
|
Blue Star Foods Corp.
Blue Star Takes Action to Strengthen Measures to Safeguard Shareholder Interests Miami, FL, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or...
Blue Star Foods Enters into Supply Agreement for Up to $4 Million Annually with Just Food For Dogs
January 31, 2023 08:30 ET
|
Blue Star Foods Corp.
Will Supply Wild Caught Cod as Ingredient for its Gourmet Dog Food Miami, FL, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ:...
Blue Star Foods Highlights Sustainability in New ESG Report
January 24, 2023 08:30 ET
|
Blue Star Foods Corp.
Working to Improve the Lives of Artisan Fishers and the Sustainability of the Fishery Miami, FL, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or...
Revolution Medicines to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023 07:00 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...